Cullen/Frost Bankers, Inc. Johnson & Johnson Transaction History

Cullen/Frost Bankers, Inc.

$7.23 Billion
Q3 2024

A detailed history of Cullen/Frost Bankers, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 341,907 shares of JNJ stock, worth $49.9 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares

341,907

Previous 337,323 1.36%

Holding current value

$49.9 Million

Previous $49.3 Million 12.38%

% of portfolio

0.77%

Previous 0.72%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$145.48 - $167.38 $666,880 - $767,269	4,584 Added 1.36%	341,907 $55.4 Million
Q2 2024 Aug 05, 2024	SELL	$144.38 - $157.78 $732,872 - $800,891	-5,076 Reduced 1.48%	337,323 $49.3 Million
Q1 2024 May 10, 2024	SELL	$155.22 - $162.74 $366,940 - $384,717	-2,364 Reduced 0.69%	342,399 $54.2 Million
Q4 2023 Feb 06, 2024	SELL	$145.6 - $158.88 $2.39 Million - $2.6 Million	-16,388 Reduced 4.54%	344,763 $54 Million
Q3 2023 Nov 02, 2023	BUY	$155.75 - $174.48 $1 Million - $1.13 Million	6,451 Added 1.82%	361,151 $56.2 Million
Q2 2023 Aug 04, 2023	SELL	$154.35 - $166.11 $331,698 - $356,970	-2,149 Reduced 0.6%	354,700 $58.7 Million
Q1 2023 May 05, 2023	BUY	$151.05 - $180.26 $607,674 - $725,185	4,023 Added 1.14%	356,849 $55.3 Million
Q4 2022 Feb 13, 2023	BUY	$160.2 - $179.79 $4.48 Million - $5.03 Million	27,965 Added 8.61%	352,826 $62.3 Million
Q3 2022 Nov 07, 2022	BUY	$161.33 - $179.52 $1.28 Million - $1.42 Million	7,927 Added 2.5%	324,861 $53.1 Million
Q2 2022 Aug 05, 2022	BUY	$168.19 - $186.01 $1.41 Million - $1.56 Million	8,371 Added 2.71%	316,934 $56.3 Million
Q1 2022 May 09, 2022	SELL	$158.14 - $179.59 $70,214 - $79,737	-444 Reduced 0.14%	308,563 $54.7 Million
Q4 2021 Feb 07, 2022	SELL	$155.93 - $173.01 $1.04 Million - $1.15 Million	-6,665 Reduced 2.11%	309,007 $52.9 Million
Q3 2021 Nov 04, 2021	SELL	$161.5 - $179.47 $1.19 Million - $1.32 Million	-7,362 Reduced 2.28%	315,672 $51 Million
Q2 2021 Aug 05, 2021	BUY	$159.48 - $171.07 $853,696 - $915,737	5,353 Added 1.69%	323,034 $53.2 Million
Q1 2021 May 05, 2021	BUY	$153.07 - $170.48 $875,101 - $974,634	5,717 Added 1.83%	317,681 $52.2 Million
Q4 2020 Feb 08, 2021	BUY	$137.11 - $157.38 $339,758 - $389,987	2,478 Added 0.8%	311,964 $49.1 Million
Q3 2020 Nov 05, 2020	SELL	$140.38 - $153.83 $664,980 - $728,692	-4,737 Reduced 1.51%	309,486 $46.1 Million
Q2 2020 Aug 05, 2020	BUY	$128.81 - $155.51 $6.66 Million - $8.05 Million	51,740 Added 19.71%	314,223 $44.2 Million
Q1 2020 May 01, 2020	BUY	$111.14 - $153.99 $1 Million - $1.39 Million	9,025 Added 3.56%	262,483 $34.4 Million
Q4 2019 Feb 06, 2020	BUY	$127.5 - $146.44 $555,772 - $638,331	4,359 Added 1.75%	253,458 $37 Million
Q3 2019 Nov 01, 2019	SELL	$126.95 - $142.14 $1.06 Million - $1.19 Million	-8,360 Reduced 3.25%	249,099 $32.2 Million
Q2 2019 Aug 01, 2019	SELL	$131.15 - $144.24 $192,921 - $212,177	-1,471 Reduced 0.57%	257,459 $35.9 Million
Q1 2019 Apr 30, 2019	BUY	$125.72 - $139.79 $3.13 Million - $3.48 Million	24,863 Added 10.62%	258,930 $36.2 Million
Q4 2018 Feb 06, 2019	BUY	$122.84 - $147.84 $7.84 Million - $9.44 Million	63,848 Added 37.51%	234,067 $30.2 Million
Q3 2018 Oct 29, 2018	SELL	$121.58 - $142.88 $755,862 - $888,284	-6,217 Reduced 3.52%	170,219 $23.5 Million
Q2 2018 Jul 27, 2018	SELL	$119.4 - $131.76 $1.7 Million - $1.88 Million	-14,265 Reduced 7.48%	176,436 $21.4 Million
Q1 2018 May 11, 2018	SELL	$125.1 - $148.14 $879,578 - $1.04 Million	-7,031 Reduced 3.56%	190,701 $24.4 Million
Q4 2017 Jan 31, 2018	SELL	$131.22 - $143.62 $964,335 - $1.06 Million	-7,349 Reduced 3.58%	197,732 $27.6 Million
Q3 2017 Nov 02, 2017	BUY	$129.47 - $135.38 $26.6 Million - $27.8 Million	205,081	205,081 $26.7 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.

Account

Cullen/Frost Bankers, Inc. Johnson & Johnson Transaction History